Literature DB >> 19015597

Serum cystatin C is related to pulse wave velocity even in subjects with normal serum creatinine.

Sang Heon Song1, Ihm Soo Kwak, Young Joo Kim, Hee Sun Lee, Harin Rhee, Dong Won Lee, Yang Ho Kang, Seong-Jang Kim.   

Abstract

We hypothesized that serum cystatin C can be a more predictable marker of arterial stiffness than serum creatinine and creatinine-based glomerular filtration rate (GFR). The aim of this study is to evaluate whether serum cystatin C is related to arterial stiffness independently of serum creatinine in subjects for whom serum creatinine is normal. A total of 2,018 individuals (1,120 males, 898 females) were enrolled. Mean brachial-ankle pulse wave velocity (baPWV) was used as a marker of arterial stiffness and sex-specific analysis was performed. A positive relationship between baPWV and serum cystatin C (Y=1109.0548+329.9102X, r(2)=0.056, p<0.001) was found in males. Stepwise multivariate regression analysis in males showed that age, waist circumference, heart rate, cystatin C level, triglyceride level, and fasting glucose were independent contributors to baPWV. In females, a positive relationship between baPWV and serum cystatin C (Y=1035.7828+402.2970X, r(2)=0.090, p<0.001) was found. Stepwise multivariate regression analysis showed that age, heart rate, cystatin C level, fasting glucose and insulin level were independent contributors to baPWV. Age, heart rate, fasting glucose and serum cystatin C were the significant variables in both genders that contributed to baPWV. In conclusion, this study confirmed that serum cystatin C was related to pulse wave velocity even in subjects with normal serum creatinine. This finding suggested that cystatin C could be a more predictable marker of arterial stiffness than serum creatinine and creatinine-based GFR.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19015597     DOI: 10.1291/hypres.31.1895

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  7 in total

1.  Serum cystatin C as a predictor for cardiovascular events in end-stage renal disease patients at the initiation of dialysis.

Authors:  Min Ji Shin; Sang Heon Song; Ihm Soo Kwak; Soo Bong Lee; Dong Won Lee; Eun Young Seong; Il Young Kim; Harin Rhee; Naria Lee
Journal:  Clin Exp Nephrol       Date:  2012-01-26       Impact factor: 2.801

2.  The association between renal function biomarkers and subclinical cardiovascular measures in African Caribbean families.

Authors:  Hu Li; Allison Kuipers; Candace M Kammerer; Clareanne H Bunker; Lewis H Kuller; Iva Miljkovic; Alan L Patrick; Victor W Wheeler; Joseph M Zmuda
Journal:  Ethn Dis       Date:  2013       Impact factor: 1.847

Review 3.  State of the Art Review: Brachial-Ankle PWV.

Authors:  Hirofumi Tomiyama; Kazuki Shiina
Journal:  J Atheroscler Thromb       Date:  2020-05-23       Impact factor: 4.928

Review 4.  Risk for subsequent hypertension and cardiovascular disease after living kidney donation: is it clinically relevant?

Authors:  Charles J Ferro; Jonathan N Townend
Journal:  Clin Kidney J       Date:  2021-12-13

5.  Estimation of Glomerular Filtration Rate Based on Serum Cystatin C versus Creatinine in a Uruguayan Population.

Authors:  Inés Lujambio; Mariana Sottolano; Leonella Luzardo; Sebastián Robaina; Nadia Krul; Lutgarde Thijs; Florencia Carusso; Alicia da Rosa; Ana Carina Ríos; Alicia Olascoaga; Mariela Garau; Liliana Gadola; Oscar Noboa; Jan A Staessen; José Boggia
Journal:  Int J Nephrol       Date:  2014-08-24

6.  Serum cystatin C is a determinant of central pressure augmentation index measured by oscillometric method in renal transplant recipients.

Authors:  Miriana Dinic; Nicolas Maillard; Damien Thibaudin; Martin Jannot; Ingrid Masson; Eric Alamartine; Christophe Mariat
Journal:  BMC Nephrol       Date:  2014-12-11       Impact factor: 2.388

7.  Association between central aortic pulsatility and glomerular filtration rate in patients with coronary artery disease.

Authors:  Serkan Duyuler; Pınar Türker Bayır; Ümit Güray; Abdülkadir Yıldız; Ahmet Korkmaz; Kadir Gökhan Atılgan
Journal:  Anatol J Cardiol       Date:  2015-11-30       Impact factor: 1.596

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.